Works matching IS 13518216 AND DT 2016 AND VI 22 AND IP 2

Results: 34

A survey of platelet aggregometry tests in a tertiary centre.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e111, doi. 10.1111/hae.12889

By:

Webster, G.;
Nash, M. J.;
Thachil, J.

Publication type:

Article

Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 240, doi. 10.1111/hae.12830

By:

Ragni, M. V.;
DiMichele, D. M.;
Hay, C. M.;
Malec, L. M.;
Seaman, C. D.;
Li, J.;
Yabes, J. G.;
Butenas, S.;
Brummel‐Ziedins, K.

Publication type:

Article

Simultaneous bilateral total knee arthroplasty in patients with haemophilia: a safe and cost-effective procedure?

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 303, doi. 10.1111/hae.12832

By:

Mortazavi, S. M. J.;
Haghpanah, B.;
Ebrahiminasab, M. M.;
Baghdadi, T.;
Hantooshzadeh, R.;
Toogeh, G.

Publication type:

Article

Joint surgery in von Willebrand disease: a multicentre cross-sectional study.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 256, doi. 10.1111/hae.12834

By:

Galen, K. P. M.;
Meijer, K.;
Vogely, H. C.;
Eikenboom, J.;
Schutgens, R. E. G.;
Cnossen, M. H.;
Fijnvandraat, K.;
Bom, J. G.;
Laros‐van Gorkom, B. A. P.;
Leebeek, F. W. G.;
Mauser‐Bunschoten, E. P.

Publication type:

Article

Developing a multidisciplinary Young Women's Blood Disorders Program: a single-centre approach with guidance for other centres.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 199, doi. 10.1111/hae.12836

By:

Zia, A.;
Lau, M.;
Journeycake, J.;
Sarode, R.;
Marshall, J.;
De Simone, N.;
Wilson, E.;
Winborn, A.;
Kouides, P.

Publication type:

Article

Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e80, doi. 10.1111/hae.12901

By:

Fischer, K.;
Nijdam, A.;
Holmström, M.;
Petrini, P.;
Ljung, R.;
Schouw, Y. T.;
Berntorp, E.

Publication type:

Article

Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 308, doi. 10.1111/hae.12784

By:

Lillicrap, D.;
Schiviz, A.;
Apostol, C.;
Wojciechowski, P.;
Horling, F.;
Lai, C. K.;
Piskernik, C.;
Hoellriegl, W.;
Lollar, P.

Publication type:

Article

Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 268, doi. 10.1111/hae.12786

By:

Pénzes, K.;
Vezina, C.;
Bereczky, Z.;
Katona, É.;
Kun, M.;
Muszbek, L.;
Rivard, G. E.

Publication type:

Article

Pain in haemophilia: are we listening?

Published in:

2016

By:

Humphries, T. J.;
Kessler, C. M.

Publication type:

Editorial

Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 188, doi. 10.1111/hae.12856

By:

Wiewel‐Verschueren, S.;
Arendz, I. J.;
M. Knol, H.;
Meijer, K.

Publication type:

Article

Treatment of subchondral cysts in patients with haemophilia.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 292, doi. 10.1111/hae.12800

By:

Caviglia, H.;
Galatro, G.;
Cambiaggi, G.;
Landro, M. E.;
Candela, M.;
Neme, D.

Publication type:

Article

Is it possible to use autologous adipose graft for wound repair in patients with coagulation disorders?

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 298, doi. 10.1111/hae.12804

By:

Caviglia, H.;
Landro, M. E.;
Gallo, E.;
Douglas Price, A. L.;
Galatro, G.;
Neme, D.

Publication type:

Article

Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 179, doi. 10.1111/hae.12805

By:

Arachchillage, D. R. J.;
Makris, M.

Publication type:

Article

The role of rotational thromboelastometry in assessment of haemostasis during pregnancy in women with factor XI deficiency.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 276, doi. 10.1111/hae.12807

By:

Davies, J.;
Harper, A.;
Kadir, R. A.

Publication type:

Article

Progress toward meeting the needs of adolescent females with bleeding disorders.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 196, doi. 10.1111/hae.12870

By:

Konkle, B. A.

Publication type:

Article

Successful immune tolerance induction with von Willebrand factor containing concentrate in an adult with haemophilia A and chronic inhibitor - a case study.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e104, doi. 10.1111/hae.12871

By:

Sholzberg, M.;
Floros, G.;
Teitel, J.

Publication type:

Article

The utility of VWF multimer analysis in response to the desmopressin administration for the diagnosis of severe type 1 von Willebrand disease.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e106, doi. 10.1111/hae.12874

By:

Takeyama, M.;
Nogami, K.;
Onaka, M.;
Yada, K.;
Shida, Y.;
Shima, M.

Publication type:

Article

Successful haemostatic management of replacement of the ascending aorta for type A acute aortic dissection in a patient with mild haemophilia B.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e109, doi. 10.1111/hae.12879

By:

Takeyama, M.;
Nogami, K.;
Shida, Y.;
Yada, K.;
Hirose, T.;
Hayata, Y.;
Tabayashi, N.;
Taniguchi, S.;
Akasaki, Y.;
Kawaraguchi, Y.;
Kawaguchi, M.;
Shima, M.

Publication type:

Article

Fracture risk in patients with haemophilia.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e113, doi. 10.1111/hae.12892

By:

Khanna, P.;
Lee, A.;
Poon, M.‐C.

Publication type:

Article

Validation of the prediction model for inhibitor development in PUPs with severe haemophilia A.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e116, doi. 10.1111/hae.12895

By:

Hashemi, S. M.;
Fischer, K.;
Moons, K. G. M.;
Berg, H. M.

Publication type:

Article

Von Willebrand disease in the emergency department.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 263, doi. 10.1111/hae.12841

By:

Livesey, K.;
Yealy, D. M.;
Li, J.;
Moore, C. G.;
Ragni, M. V.

Publication type:

Article

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 248, doi. 10.1111/hae.12847

By:

Holme, P. A.;
Combescure, C.;
Tait, R.C.;
Berntorp, E.;
Rauchensteiner, S.;
Moerloose, P.;
Pabinger‐Fasching, Ingrid;
Hermans, Cedric;
d'Oiron, Roseline;
Negrier, Claude;
Klamroth, Robert;
Marquardt, Natascha;
Staritz, Peter;
Martinowitz, Uri;
Kenet, Gili;
Lubetsky, Aharon;
Cannavò, Nino;
Tagliaferri, Annarita;
Schutgens, Roger;
Windyga, Jerzy

Publication type:

Article

Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 214, doi. 10.1111/hae.12791

By:

Stedman, C. A. M.;
Hyland, R. H.;
Ding, X.;
Pang, P. S.;
McHutchison, J. G.;
Gane, E. J.

Publication type:

Article

Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 218, doi. 10.1111/hae.12792

By:

Altisent, C.;
Martorell, M.;
Crespo, A.;
Casas, L.;
Torrents, C.;
Parra, R.

Publication type:

Article

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 225, doi. 10.1111/hae.12793

By:

Lissitchkov, T.;
Hampton, K.;
Depka, M.;
Hay, C.;
Rangarajan, S.;
Tuddenham, E.;
Holstein, K.;
Huth‐Kühne, A.;
Pabinger, I.;
Knaub, S.;
Bichler, J.;
Oldenburg, J.

Publication type:

Article

Novel, human cell line-derived recombinant factor VIII (Human-cl rh FVIII, Nuwiq®) in children with severe haemophilia A: efficacy, safety and pharmacokinetics.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 232, doi. 10.1111/hae.12797

By:

Klukowska, A.;
Szczepański, T.;
Vdovin, V.;
Knaub, S.;
Jansen, M.;
Liesner, R.

Publication type:

Article

Hindfoot fusion in haemophilic arthropathy: 6-year mean follow-up of 41 procedures performed in 28 adult patients.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e87, doi. 10.1111/hae.12863

By:

Brkljac, M.;
Shah, S.;
Hay, C.;
Rodriguez‐Merchan, E. C.

Publication type:

Article

Second trimester prenatal diagnosis in Glanzmann's Thrombasthenia.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e99, doi. 10.1111/hae.12865

By:

Kulkarni, B.;
Ghosh, K.;
Shetty, S.

Publication type:

Article

Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. e101, doi. 10.1111/hae.12867

By:

Pouplard, C.;
Ternisien, C.;
Desconclois, C.;
Lasne, D.;
Aillaud, M.‐F.;
Caron, C.

Publication type:

Article

Five in one therapy for graded treatment of haemophilic arthritis.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 208, doi. 10.1111/hae.12746

By:

Liu, S. X.;
Li, P. B.;
Liu, Y. G.;
Wang, P. H.

Publication type:

Article

Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin.

Published in:

Haemophilia, 2016, v. 22, n. 2, p. 285, doi. 10.1111/hae.12811

By:

Obaji, S.;
Alikhan, R.;
Rayment, R.;
Carter, P.;
Macartney, N.;
Collins, P.

Publication type:

Article

Editorial Board.

Published in:: Haemophilia, 2016, v. 22, n. 2, p. 161, doi. 10.1111/hae.12815
Publication type:: Article

Table of Contents.

Published in:: Haemophilia, 2016, v. 22, n. 2, p. 163, doi. 10.1111/hae.12816
Publication type:: Article

Instructions for Authors.

Published in:: Haemophilia, 2016, v. 22, n. 2, p. 320, doi. 10.1111/hae.12817
Publication type:: Article

Works matching IS 13518216 AND DT 2016 AND VI 22 AND IP 2

A survey of platelet aggregometry tests in a tertiary centre.

Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction.

Simultaneous bilateral total knee arthroplasty in patients with haemophilia: a safe and cost-effective procedure?

Joint surgery in von Willebrand disease: a multicentre cross-sectional study.

Developing a multidisciplinary Young Women's Blood Disorders Program: a single-centre approach with guidance for other centres.

Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.

Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody.

Pain in haemophilia: are we listening?

Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.

Treatment of subchondral cysts in patients with haemophilia.

Is it possible to use autologous adipose graft for wound repair in patients with coagulation disorders?

Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.

The role of rotational thromboelastometry in assessment of haemostasis during pregnancy in women with factor XI deficiency.

Progress toward meeting the needs of adolescent females with bleeding disorders.

Successful immune tolerance induction with von Willebrand factor containing concentrate in an adult with haemophilia A and chronic inhibitor - a case study.

The utility of VWF multimer analysis in response to the desmopressin administration for the diagnosis of severe type 1 von Willebrand disease.

Successful haemostatic management of replacement of the ascending aorta for type A acute aortic dissection in a patient with mild haemophilia B.

Fracture risk in patients with haemophilia.

Validation of the prediction model for inhibitor development in PUPs with severe haemophilia A.

Von Willebrand disease in the emergency department.

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe.

Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.

Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes.

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup>) in adults with severe haemophilia A: efficacy and safety.

Novel, human cell line-derived recombinant factor VIII (Human-cl rh FVIII, Nuwiq<sup>®</sup>) in children with severe haemophilia A: efficacy, safety and pharmacokinetics.

Hindfoot fusion in haemophilic arthropathy: 6-year mean follow-up of 41 procedures performed in 28 adult patients.

Second trimester prenatal diagnosis in Glanzmann's Thrombasthenia.

Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF<sup>®</sup>-treated patients.

Five in one therapy for graded treatment of haemophilic arthritis.

Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin.

Editorial Board.

Table of Contents.

Instructions for Authors.